Kim Eun Young, Jun Kyong Hwa, Kim Shinn Young, Chin Hyung Min
Department of Surgery, UIjeongbu St. Mary Hospital.
Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Medicine (Baltimore). 2020 Nov 20;99(47):e23363. doi: 10.1097/MD.0000000000023363.
Among patients undergoing gastrectomy for gastric cancer, the impact of anthropometric indices on surgical outcomes is not well-established. The aim of this study was to evaluate the prognostic significance of the skeletal muscle index (SMI) and body mass index (BMI) on overall survival (OS) in patients with gastric cancer.A total of 305 patients who underwent curative gastrectomy for gastric adenocarcinoma between January 2005 and March 2008 were enrolled. Patients were classified into groups based on the SMI and BMI. The SMI was measured by preoperative abdominal computed tomography (CT). The SMI groups were classified based on gender-specific cut-off values obtained by means of optimum stratification. BMI groups were divided according to the World Health Organization definition of obesity for Asians.The mean SMI was 58.2 cm/m and the mean BMI was 23.2 kg/m. One hundred fifteen (37.7%) patients had sarcopenia based on the diagnostic cut-off values (56.2 cm/m for men and 53.6 cm/m for women). Apart from gender, there were no significant differences in patient characteristics or surgical outcomes between the SMI groups. In the underweight group, tumor (T) stage, tumor-node-metastasis (TNM) stage, number of retrieved lymph nodes, D2 dissection, and hospital stay were significantly increased compared with the overweight/obese group. High and low BMI, and low SMI, were independent prognostic factors for OS (hazard ratio [HR] = 2.355, 1.736, and 1.607, respectively; P = .009, .023, and .033, respectively).SMI and BMI did not impact perioperative morbidity in patients undergoing gastrectomy for gastric cancer. Both SMI and BMI are useful prognostic factors for OS in gastric cancer patients after gastrectomy.
在接受胃癌胃切除术的患者中,人体测量指标对手术结果的影响尚未明确。本研究旨在评估骨骼肌指数(SMI)和体重指数(BMI)对胃癌患者总生存期(OS)的预后意义。
共有305例在2005年1月至2008年3月期间接受根治性胃切除术治疗胃腺癌的患者入组。患者根据SMI和BMI分组。SMI通过术前腹部计算机断层扫描(CT)测量。SMI组根据通过最佳分层获得的性别特异性临界值进行分类。BMI组根据世界卫生组织对亚洲人的肥胖定义进行划分。
平均SMI为58.2 cm/m,平均BMI为23.2 kg/m。根据诊断临界值(男性为56.2 cm/m,女性为53.6 cm/m),115例(37.7%)患者存在肌肉减少症。除性别外,SMI组之间的患者特征或手术结果无显著差异。与超重/肥胖组相比,体重过轻组的肿瘤(T)分期、肿瘤-淋巴结-转移(TNM)分期、回收淋巴结数量、D2淋巴结清扫和住院时间显著增加。高BMI和低BMI以及低SMI是OS的独立预后因素(风险比[HR]分别为2.355、1.736和1.607;P分别为0.009、0.023和0.033)。
SMI和BMI对接受胃癌胃切除术的患者围手术期发病率无影响。SMI和BMI都是胃癌患者胃切除术后OS的有用预后因素。